Fondazione Epatocentro Ticino

Lugano 6900

0 studies enrolling now · 3 studies all time

What they study most

Hepatitis C, NASH - Nonalcoholic Steatohepatitis, Primary Biliary Cirrhosis

Studies at this site

• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. — Completed